Objectifs de la session
Update on melasma: oral tranexamic acid, topical cysteamine and isobutylamido thiazolyl resorcinol, low-fluence lasers, and the role of vascular and hormonal factors in relapse. Maintenance protocols will be discussed.
Update on melasma: oral tranexamic acid, topical cysteamine and isobutylamido thiazolyl resorcinol, low-fluence lasers, and the role of vascular and hormonal factors in relapse. Maintenance protocols will be discussed.